Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kanner, A. M.
Right arrow Articles by Iriarte, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kanner, A. M.
Right arrow Articles by Iriarte, J.
Neurology 1999;53:933
© 1999 American Academy of Neurology


Articles

Psychiatric and neurologic predictors of psychogenic pseudoseizure outcome

A. M. Kanner, MD, J. Parra, MD, M. Frey, RN, CGNP, G. Stebbins, PhD, S. Pierre–Louis, MD and J. Iriarte, MD, PhD

From the Department of Neurological Sciences, Rush Medical College and Rush Epilepsy Center, Rush-Presbyterian-St. Luke’s Medical Center, Chicago, IL.

Address correspondence and reprint requests to Dr. Andres M. Kanner, Rush Epilepsy Center, Room 348, Murdock Building, Rush-Presbyterian-St. Luke’s Medical Center, 1653 West Congress Parkway, Chicago, IL 60612.

OBJECTIVE: To investigate the patterns of occurrence of psychogenic pseudoseizures (PPS) of 45 consecutive patients during a 6-month period after diagnosis, and to determine whether psychiatric and neurologic variables identified previously in PPS patient series can predict their recurrence after diagnosis, and whether any of these variables are associated with a particular outcome pattern. Method:— Postdiagnosis PPS recurrence was assessed twice: during the first month and during a period ranging from the second to the sixth month. Outcome was categorized as follows: class I, complete cessation of PPS; class II, PPS only during one of the two observation periods; and class III, persistent PPS during the two observation periods. The authors used a logistic regression model to identify predictors of PPS recurrence (versus no PPS) among four neurologic and nine psychiatric variables, and compared their frequency among the three outcome classes.

RESULTS: Class I, n = 13 (29%); class II, n = 12 (27%); and class III, n = 20 (44%). The presence of an abnormal MR image predicted PPS recurrence during the second observation period with a 75% accuracy. The presence of all nine psychiatric variables predicted PPS recurrence during both the first and second observation periods with a 93% and an 89% accuracy respectively. Patients with a class III outcome had a markedly higher frequency of recurrent major depression, dissociative and personality disorders, and a history of chronic abuse. Patients with a class II outcome displayed a notably higher frequency of denial of stressors and psychosocial problems, refusal of treatment recommendations, and new somatic symptoms after disclosure of diagnosis. Conversely, one episode of major depression was the one common diagnosis in patients with a class I outcome.

CONCLUSIONS: PPS outcome after disclosure of diagnosis can be predicted by the presence of certain psychiatric characteristics. More than one psychopathogenic mechanism appears to operate in PPS.

Key words: Psychogenic pseudoseizures—Pseudoseizure outcome—Sexual abuse—Intractable epilepsy.




This article has been cited by other articles:


Home page
J. Neuropsychiatry Clin. Neurosi.Home page
W. C. LaFrance Jr., A. S. Blum, I. W. Miller, C. E. Ryan, and G. I. Keitner
Methodological Issues in Conducting Treatment Trials for Psychological Nonepileptic Seizures
J Neuropsychiatry Clin Neurosci, November 1, 2007; 19(4): 391 - 398.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
R. J. Brown, E. Cardena, E. Nijenhuis, V. Sar, and O. van der Hart
Should Conversion Disorder Be Reclassified as a Dissociative Disorder in DSM V?
Psychosomatics, October 1, 2007; 48(5): 369 - 378.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M Reuber, A J Mitchell, S J Howlett, H L Crimlisk, and R A Grunewald
Functional symptoms in neurology: questions and answers
J. Neurol. Neurosurg. Psychiatry, March 1, 2005; 76(3): 307 - 314.
[Abstract] [Full Text] [PDF]


Home page
PsychosomaticsHome page
J. Stone, M. Sharpe, and M. Binzer
Motor Conversion Symptoms and Pseudoseizures: A Comparison of Clinical Characteristics
Psychosomatics, December 1, 2004; 45(6): 492 - 499.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M Reuber, R Pukrop, J Bauer, R Derfuss, and C E Elger
Multidimensional assessment of personality in patients with psychogenic non-epileptic seizures
J. Neurol. Neurosurg. Psychiatry, May 1, 2004; 75(5): 743 - 748.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
A J Carson, S Best, K Postma, J Stone, C Warlow, and M Sharpe
The outcome of neurology outpatients with medically unexplained symptoms: a prospective cohort study
J. Neurol. Neurosurg. Psychiatry, July 1, 2003; 74(7): 897 - 900.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
P. Salmon, S. M. Al-Marzooqi, G. Baker, and J. Reilly
Childhood Family Dysfunction and Associated Abuse in Patients With Nonepileptic Seizures: Towards a Causal Model
Psychosom Med, July 1, 2003; 65(4): 695 - 700.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by AAN Enterprises, Inc.